Filing Details

Accession Number:
0001225208-18-012336
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-06 16:49:58
Reporting Period:
2018-08-03
Accepted Time:
2018-08-06 16:49:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
310158 Merck & Co. Inc. MRK Pharmaceutical Preparations (2834) 221918501
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1670690 Sanat Chattopadhyay Merck &Amp; Co., Inc.
2000 Galloping Hill Road
Kenilworth NJ 07033
Exe V-P & Pres. Mmd No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-08-03 19,208 $33.49 70,675 No 4 M Direct
Common Stock Acquisiton 2018-08-03 10,000 $37.49 80,675 No 4 M Direct
Common Stock Disposition 2018-08-03 29,208 $65.20 51,467 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2018-08-03 10,000 $0.00 10,000 $37.49
Common Stock Stock Option (right to buy) Disposition 2018-08-03 19,208 $0.00 19,208 $33.49
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2011-02-19 2020-02-18 No 4 M Direct
0 2011-05-07 2020-05-06 No 4 M Direct
Footnotes
  1. Holdings include shares acquired in dividend reinvestment transactions.
  2. The option became exercisable in equal installments on 2/19/2011, 2/19/2012 and 2/19/2013.
  3. The option became exercisable in equal installments on 5/7/2011, 5/7/2012 and 5/7/2013.